ENDOCRINE SYSTEM DISEASES
Clinical trials for ENDOCRINE SYSTEM DISEASES explained in plain language.
Never miss a new study
Get alerted when new ENDOCRINE SYSTEM DISEASES trials appear
Sign up with your email to follow new studies for ENDOCRINE SYSTEM DISEASES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New daily shot could replace calcium pills for rare hormone disorder
Disease control CompletedThis Phase 3 trial tested a daily injection of TransCon PTH, a synthetic parathyroid hormone, in 84 adults with hypoparathyroidism. The goal was to see if it could help patients maintain normal blood calcium levels while reducing their need for high-dose calcium and vitamin D sup…
Matched conditions: ENDOCRINE SYSTEM DISEASES
Phase: PHASE3 • Sponsor: Ascendis Pharma Bone Diseases A/S • Aim: Disease control
Last updated Jun 23, 2026 11:58 UTC
-
Electric pulses to the gut: a new hope for diabetes?
Disease control CompletedThis early study tested a device that uses mild electric pulses to regenerate the lining of the upper small intestine in 20 adults with type 2 diabetes. The goal was to see if the procedure is safe and could help lower blood sugar. Participants were on 2-3 diabetes pills and had …
Matched conditions: ENDOCRINE SYSTEM DISEASES
Phase: NA • Sponsor: Endogenex, Inc. • Aim: Disease control
Last updated Jun 23, 2026 11:58 UTC
-
Weekly hormone shot shows promise for Long-Term use in adults
Disease control CompletedThis study tested a once-weekly growth hormone injection (lonapegsomatropin) in 220 adults with growth hormone deficiency who had completed a prior study. The main goal was to check long-term safety and side effects over 52 weeks. Researchers also measured changes in body fat and…
Matched conditions: ENDOCRINE SYSTEM DISEASES
Phase: PHASE3 • Sponsor: Ascendis Pharma Endocrinology Division A/S • Aim: Disease control
Last updated Jun 22, 2026 12:07 UTC
-
New diabetes drug shows promise for teens in landmark trial
Disease control CompletedThis study tested a medication called tirzepatide in children and teenagers aged 10 to 17 with type 2 diabetes. Participants were already taking metformin or insulin but still had high blood sugar. The goal was to see if tirzepatide could safely lower blood sugar levels better th…
Matched conditions: ENDOCRINE SYSTEM DISEASES
Phase: PHASE3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 18, 2026 11:49 UTC
-
Money stress and diabetes: new study tests a Two-Pronged solution
Disease control CompletedThis pilot study tested whether combining financial navigation (help with costs) and peer support (connecting with others) can help adults with diabetes better manage their condition. 61 participants were randomly assigned to receive either financial navigation alone or financial…
Matched conditions: ENDOCRINE SYSTEM DISEASES
Phase: NA • Sponsor: University of Michigan • Aim: Disease control
Last updated Jun 18, 2026 11:48 UTC
-
New drug shows promise for bulging eyes in thyroid disease
Disease control CompletedThis study tested a new medicine called LASN01 in 41 adults with thyroid eye disease, a condition that causes eye bulging and discomfort. The goal was to see if LASN01 could safely reduce eye bulging compared to a placebo. Participants received either LASN01 or a dummy treatment …
Matched conditions: ENDOCRINE SYSTEM DISEASES
Phase: PHASE2 • Sponsor: Lassen Therapeutics Inc. • Aim: Disease control
Last updated Jun 17, 2026 12:04 UTC
-
New daily shot could free hypoparathyroidism patients from pills
Disease control CompletedThis study tested a daily injection called TransCon PTH in 81 adults with hypoparathyroidism, a condition where the body lacks parathyroid hormone, causing low calcium levels. The goal was to see if the drug could bring calcium levels back to normal and allow patients to stop tak…
Matched conditions: ENDOCRINE SYSTEM DISEASES
Phase: PHASE3 • Sponsor: Visen Pharmaceuticals (Shanghai) Co., Ltd. • Aim: Disease control
Last updated Jun 12, 2026 12:07 UTC
-
COVID-19's hidden impact on hormones revealed in new study
Knowledge-focused CompletedThis completed study looked at how COVID-19 infection changes hormone levels and markers of inflammation in the body. Researchers followed 220 hospitalized COVID-19 patients, testing their blood and doing physical exams at admission, during their stay, and 3 and 6 months after di…
Matched conditions: ENDOCRINE SYSTEM DISEASES
Sponsor: Istituto Auxologico Italiano • Aim: Knowledge-focused
Last updated Jun 24, 2026 02:02 UTC